{"name":"Apeiron Biologics","slug":"apeiron-biologics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTFA3UndtcFNWd01wYkFrOG5xYnZ1SWFieGNhYldkcXVfQWJlVFpXd3VOSmw3THpMTUxac1NhbWVvaW9iNTRxUjlybzVaNXJlSEhvbFZOLVJFV3BXOEJvT0FXNUZPUWM0U0p4cHVXRg?oc=5","date":"2026-01-21","type":"pipeline","source":"PharmaTimes","summary":"Peter Llewellyn-Davies - PharmaTimes","headline":"Peter Llewellyn-Davies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPY1FTVVYtdF9vYnZ4VHF1WUFSaDA1M2tGMGNmNlYwbG5yS2lVMFFNclZRS3N0WXBTQS1YLVZLWlVFUHc0R01YTEVQQWJPRFE1Y3ZycWhuSm1IZ21VRHVYRTJITlZmeVpiREJveHk5QVcybHBUYy14UjU1ZUt5SHllYTdVWVQyRUxxTkFrNl9wQk81ekhleXk3MjFR?oc=5","date":"2025-08-05","type":"pipeline","source":"Fierce Pharma","summary":"Y-mAbs signs off on $412M sale to SERB Pharmaceuticals, sending shares up 100% - Fierce Pharma","headline":"Y-mAbs signs off on $412M sale to SERB Pharmaceuticals, sending shares up 100%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPSHI4THNVN25HUGNtQVlNbFVyaVBNMWZzVGF2V3hrSXZrOFE1N0pENmlLbHNlZnFzcGktSExzeF9meW85TXZ2S1lILUFpX1J6VjFad3VZUFhFNW0xNndPOWRkVV95QUFwdTJMNWxJeGZLdHlQdEVaczhBbE1TYmMxMklZSFhwZ1B2bHVVMHlDTDJLRW5IOVc4eEs3RHI1cFo2NjAtM3o4NGJORW13cDlJ?oc=5","date":"2025-01-13","type":"pipeline","source":"Fierce Pharma","summary":"Y-mAbs splits from commercial chief, tasks new hire with growing cancer drug sales - Fierce Pharma","headline":"Y-mAbs splits from commercial chief, tasks new hire with growing cancer drug sales","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiTEFVX3lxTE1FNHFUU1F6OVJOUC1sZGNySzQ4Ri1SdWFKcFRDeDNNVDgxQXJodFNyS003U29lQ3l5cklzS3FXMlo2M2F0M04tT1hNN0M?oc=5","date":"2024-07-10","type":"deal","source":"Oncodaily","summary":"APEIRON Biologics to be Acquired by Ligand Pharmaceuticals for USD 100 Million - Oncodaily","headline":"APEIRON Biologics to be Acquired by Ligand Pharmaceuticals for USD 100 Million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE94Mm9KR2xDQmRfaUVvVWNGZkxrUXZ2NVJRVTR6RUdfT09SRTV0eS1zaXIzQVdqR2kzZE14ejZ5M3o2YTdCSDJPck9tdnl3ODFkUURWei1Wd0Y1RnVjUlZMci1NdGNYeE1mZTZJaFpVaWtCTUc0REVTaldTSVA?oc=5","date":"2024-07-09","type":"deal","source":"Pharmaceutical Technology","summary":"Ligand agrees to acquire APEIRON Biologics for $100m - Pharmaceutical Technology","headline":"Ligand agrees to acquire APEIRON Biologics for $100m","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxNR3dzU0stX2ZnQ3h6TVdiWFVkWmF0akN3SE4yQVRZLUFyVnhaNGxDemRYRldoTHQ1T3pVM1hCMlJvSnY5c3FWMjVJY0dXN3FESENUWmFMeTI0R21NWGJPV2hvc0k4cHBqRFRWRXdfWjd4Qk02M004eC13WEpRb1dheG9IVFo2Wnc?oc=5","date":"2024-07-09","type":"trial","source":"Oncology Pipeline","summary":"Ligand taps Apeiron for a new royalty stream | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline","headline":"Ligand taps Apeiron for a new royalty stream | ApexOnco - Clinical Trials news and analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxNek1nQWs1TS1MeTdxejlnTXNzNG9KYlZ3S0ZkOEo3ZUl4VENoOWlhSTQ1b1duckYxd1VxVU42b0JONkdvWjJRQ2k3OXUxaHluTzllNFQtT0JnSDZua2tZclhxQVNxU01kWllTRlFTdFFQVjNaVjNRcTl6X0RkUlJ3UGVIWQ?oc=5","date":"2024-07-09","type":"pipeline","source":"pharmaphorum","summary":"Ligand grows in cancer again with $100m Apeiron takeover - pharmaphorum","headline":"Ligand grows in cancer again with $100m Apeiron takeover","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPLUh1WmkzcWtSSG9TX05abnJsaFdKd3FsRXV2Q1RMUTU1dmVvaFh0b3ptUU1QQjhyUm5NTnRnUjByeVVqNnRLaXBRcmd3QjhOQXpGY0RCVWlTajdKT1hCanA4QXNTdU1EVjdHSlFhY0pBSWp6NGx4cnB5c1RpOVF5WnY1R3psQVdPTXdYc01TS2J0VktUZTBDOHRsQXVnMjFWMlNUaGZGdlo3cEZ3LTNGS0tUZ1k?oc=5","date":"2024-07-08","type":"deal","source":"businesswire.com","summary":"Ligand to Acquire APEIRON Biologics AG for $100 Million - businesswire.com","headline":"Ligand to Acquire APEIRON Biologics AG for $100 Million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNN0JYa0V4Tk1QWGppdHhPdG14QWRNaHl5ZHZuMDgtd2o1aU9WcTNTZnJ0bUlXZnFmTG5IRTJWdFM5cDVHUWJtX2x3Tzl1R1Q3Z1RHY1VUakRJOTh1ZjdRSDNJMFZ3LV9HeXhNa3BuVFZ6V01mY1BtVnYzR2NpVS1MRXRobUVfektVSXljQ2dLcFRqWE5Ua0xKTHByMVNqWnRr?oc=5","date":"2023-08-01","type":"pipeline","source":"BioWorld News","summary":"Renaissance launches with neuroblastoma antibody candidate - BioWorld News","headline":"Renaissance launches with neuroblastoma antibody candidate","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAJBVV95cUxOUU5fcEd4SHJtaDFWTnNDLVl6c0lNWEM1eUlDeGg0ekd5WTNXM0N4SU5CRUFQWGVpS1lsOFQteVVlLWxESExGa1A5cXdieTR0bW8wMlhnRFZsOUhvaGFGQV9GeDdrbVI5dmJzZk9JRXhZemJ5bk5idmtsQ1JvRGVySkRZQWRPOEtuRWFFNVRHVHdTVkVXdU5QZnRvZE00eUpXdkI0M0U4TnlLSEgtb25UbTVmZkliOEozeG1wTDY1MGRjT1lNdUEwcHdXZmdqLVdMRV9hNHY5aUhFSDdNam8xVVh0bndFWVVmN3FmOG0zV2hYdTFjLXlJUFpCMnk3WF9iNjBMdjlYNlV6X1E4bmJDWA?oc=5","date":"2021-08-17","type":"regulatory","source":"Via TT","summary":"BeiGene and EUSA Pharma Announce China NMPA Approval of QARZIBA ® (Dinutuximab Beta) for Patients With High-Risk Neuroblastoma - Via TT","headline":"BeiGene and EUSA Pharma Announce China NMPA Approval of QARZIBA ® (Dinutuximab Beta) for Patients With High-Risk Neurobl","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNN2dYYkJISFpIZ0ZkMDV4ZkIwWnN4QmplQmJ2MEVibWtaSTV0OFNzazFSWUJ1aE50NU5MaXJFVURkSjhnRDRKUWljb1RnTWwzVHpvOWZ3VU9UMDl2SHI0ekVJRVd2Vkhad25rUEdScjMwSVFrNU9oWFlnd0JUNGVQUkVjaTJ3ckdCLWFoS0RDTmNyNXBSWmZaN0kyVzdwbkpzTFJqTHpxUkZjLXhENklkQmtBUnhoaWIy?oc=5","date":"2020-03-26","type":"pipeline","source":"European Pharmaceutical Review","summary":"Potential COVID-19 therapeutics currently in development - European Pharmaceutical Review","headline":"Potential COVID-19 therapeutics currently in development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE9NYWs2SkF3TnRuQ1duVVRhM1J3blFDb0RudEx4Rk9tVUlDbmVLLWNydGp5UkdPSWlRY3doNXdnUGVxekhKNDNKeldfcll1SHRZVmZMZEk4WUV0R09sdWpkR01FdkV3LTdZRmlZN0pqUlZpWTJVdUE?oc=5","date":"2015-09-17","type":"deal","source":"PMLiVE","summary":"Pharma deals in August 2015 - PMLiVE","headline":"Pharma deals in August 2015","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}